NYSEARCA:JHMD

John Hancock Multifactor Developed International ETF Stock Forecast, Price & News

$34.14
+0.45 (+1.34 %)
(As of 09/21/2021 12:00 AM ET)
Add
Today's Range
$34.04
$34.17
50-Day Range
$32.90
$35.10
52-Week Range
$26.12
$35.70
Volume5,061 shs
Average Volume28,820 shs
Market Capitalization$518.85 million
P/E RatioN/A
Dividend Yield2.71%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive JHMD News and Ratings via Email

Sign-up to receive the latest news and ratings for John Hancock Multifactor Developed International ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer John Hancock
Fund NameJohn Hancock Multifactor Developed International ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:JHMD
Inception Date12/15/2016
Fund ManagerJoel Schneider, Lukas Smart
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkJohn Hancock Dimensional Developed International Index
CategoryBroad Equity
FocusBroad Equity
Development LevelDeveloped Markets
RegionGlobal Ex-U.S.

Fund Statistics

Assets Under Management$515.01 million
Average Daily Volume$15,757.60
Discount/Premium-0.20%

ETF Expenses

Management Fee0.35%
Other Expenses0.10%
Total Expenses0.45%
Fee Waiver-0.06%
Net Expenses0.39%

Administrator, Advisor and Custodian

AdministratorJohn Hancock Advisers, LLC
AdvisorJohn Hancock Advisers, LLC
CustodianState Street Bank and Trust Company
DistributorForeside Fund Services, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerSusquehanna

Geographic Exposure of JHMD

Currency Exposure of JHMD

Sector Exposure of JHMD

Industry Exposure of JHMD

speech bubbles
speech bubbles











John Hancock Multifactor Developed International ETF (NYSEARCA:JHMD) Frequently Asked Questions

What stocks does MarketBeat like better than John Hancock Multifactor Developed International ETF?

Wall Street analysts have given John Hancock Multifactor Developed International ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but John Hancock Multifactor Developed International ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has John Hancock Multifactor Developed International ETF's stock price been impacted by Coronavirus?

John Hancock Multifactor Developed International ETF's stock was trading at $24.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, JHMD stock has increased by 42.2% and is now trading at $34.1350.
View which stocks have been most impacted by COVID-19
.

Is John Hancock Multifactor Developed International ETF a good dividend stock?

John Hancock Multifactor Developed International ETF pays an annual dividend of $0.92 per share and currently has a dividend yield of 2.71%.
View John Hancock Multifactor Developed International ETF's dividend history.

What other stocks do shareholders of John Hancock Multifactor Developed International ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other John Hancock Multifactor Developed International ETF investors own include American Express (AXP), John Hancock Premium Dividend Fund (PDT), John Hancock Income Securities Trust (JHS) and John Hancock Tax-Advantaged Dividend Income Fund (HTD).

What is John Hancock Multifactor Developed International ETF's stock symbol?

John Hancock Multifactor Developed International ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "JHMD."

Who are John Hancock Multifactor Developed International ETF's major shareholders?

John Hancock Multifactor Developed International ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include The Manufacturers Life Insurance Company (66.82%), Evensky & Katz LLC (8.61%), Morgan Stanley (3.07%), Morgan Stanley (3.07%), Brinker Capital Investments LLC (1.68%) and LPL Financial LLC (1.15%).

Which institutional investors are selling John Hancock Multifactor Developed International ETF stock?

JHMD stock was sold by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Susquehanna International Group LLP, Evensky & Katz LLC, Mercer Global Advisors Inc. ADV, Envestnet Asset Management Inc., Brinker Capital Investments LLC, Royal Bank of Canada, and Orion Portfolio Solutions LLC.

Which institutional investors are buying John Hancock Multifactor Developed International ETF stock?

JHMD stock was purchased by a variety of institutional investors in the last quarter, including Thrivent Financial for Lutherans, Morgan Stanley, Morgan Stanley, Advisor Group Holdings Inc., Strategic Blueprint LLC, LPL Financial LLC, Dynamic Advisor Solutions LLC, and Commonwealth Equity Services LLC.

How do I buy shares of John Hancock Multifactor Developed International ETF?

Shares of JHMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is John Hancock Multifactor Developed International ETF's stock price today?

One share of JHMD stock can currently be purchased for approximately $34.14.

How much money does John Hancock Multifactor Developed International ETF make?

John Hancock Multifactor Developed International ETF has a market capitalization of $518.85 million.


This page was last updated on 9/22/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.